Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.
Clinical trials sponsored by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd., explained in plain language.
-
New hope for ulcerative colitis sufferers: drug trial launches
Disease control Not yet recruitingThis study tests a new drug called SSGJ-627 in 288 adults with moderate to severe ulcerative colitis, a chronic bowel disease. The goal is to see if it safely controls symptoms like bleeding and diarrhea. Participants must have tried other treatments without success.
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug 608 aims to ease hidden arthritis pain
Disease control Not yet recruitingThis study tests a drug called 608 in 380 adults with non-radiographic axial spondyloarthritis, a form of arthritis that causes back pain and stiffness but doesn't show up on X-rays. Participants will receive either 608 or a placebo injection to see if the drug reduces pain and i…
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC